BioCentury
ARTICLE | Financial News

TCR2 raises $44.5M in series A round

December 8, 2016 12:51 AM UTC

Immuno-oncology company TCR2 Therapeutics Inc. (Cambridge, Mass.) raised $44.5 million in a series A round led by MPM Capital and F2 Ventures...